Test Summary Sheet for:

Purpose
Therapeutic Drug Monitoring
Method(s)
Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES)
Suggested CPT Code(s)
80178
New York State Approval Status

Approved

Turnaround Time

8 days

Test Includes
1 Lithium Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) mEq/L 0.039 Metal/Element

Test Also Known As
Eskalith®; Libalith-S®; Lithane®; Lithobid®
Specimen Type
RBCs
Requested Volume
2 mL
Minimum Volume
0.7 mL
Special Handling
Submit in container with a non-Lithium based anticoagulant. Tubes containing Lithium based anticoagulants are not acceptable. Centrifuge and separate RBCs into an acid washed screw capped vial within two hours of collection.
Specimen Container
Royal Blue top tube (Trace metal-free; EDTA)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Received Room Temperature. Light Green top tube (Lithium Heparin).

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: Not Stable
Refrigerated: Undetermined
Frozen (-20 °C): Undetermined
1 Lithium Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) mEq/L 0.039 Metal/Element

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.